First use of export control system since it was issued in January
A shipment of over a quarter million AstraZeneca-Oxford vaccines destined for Australia has been blocked from leaving the European Union, in the first use of an export control system instituted by the bloc to make sure big pharmaceutical companies would respect their contracts.
The move, affecting only a small number of vaccines, underscores a growing frustration within the 27-nation bloc about the slow rollout of its vaccine drive and the shortfall of promised vaccine deliveries, especially by Anglo-Swedish AstraZeneca.
The ban came at the behest of Italy, and the EU did not raise objections to the tougher line Rome has adopted in dealing with vaccine shortages in the bloc since a new government led by Mario Draghi came into power last month.
Italy's objections centred both on the general shortage of supplies in the EU and on "the delays in the supply of vaccines by AstraZeneca to the EU and Italy," a Foreign Ministry statement said.
It said it also intervened because of the size of the shipment, more than 250,700 doses, that would go to Australia, which it did not consider a vulnerable nation.
Italy said it had informed the company on Tuesday. AstraZeneca refused to comment. The Financial Times first reported on the issue late Thursday.